Surgery Partners (SGRY) Long-Term Deferred Tax (2015 - 2024)

Surgery Partners' Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $79.2 million for Q3 2024.

• In Q3 2024, Long-Term Deferred Tax fell 24.57% year-over-year to $79.2 million; the TTM figure through Sep 2024 stood at $79.2 million (down 24.57% YoY), while the FY2023 annual figure was $89.5 million, down 2.19% from the prior year.
• Long-Term Deferred Tax came in at $79.2 million for Q3 2024 at Surgery Partners, down from $81.8 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $129.8 million in Q2 2021 to a low of $79.2 million in Q3 2024.
• A 5-year average of $106.3 million and a median of $105.7 million in 2023 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax increased 26.44% in 2020 and dropped 24.57% in 2024, its largest moves.
• Surgery Partners' Long-Term Deferred Tax stood at $124.8 million in 2020, then declined by 8.33% to $114.4 million in 2021, then dropped by 20.02% to $91.5 million in 2022, then retreated by 2.19% to $89.5 million in 2023, then slipped by 11.51% to $79.2 million in 2024.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $79.2 million, $81.8 million, and $87.0 million for Q3 2024, Q2 2024, and Q1 2024 respectively.

Peer Comparison